| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vectura Group plc (PINK: VEGPF)
VEGPF Technical Analysis
1.5
| As on 1st Nov 2021 VEGPF SHARE Price closed @ 1.77 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.09 & Sell for SHORT-TERM with Stoploss of 1.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VEGPFSHARE Price
| Open | 1.77 | Change | Price | % |
| High | 1.77 | 1 Day | 0.00 | 0.00 |
| Low | 1.77 | 1 Week | -0.49 | -21.68 |
| Close | 1.77 | 1 Month | -0.51 | -22.37 |
| Volume | N/A | 1 Year | 0.45 | 34.09 |
| 52 Week High 2.75 | 52 Week Low 1.32 | ||||
PINK USA Most Active Stocks
| CYBL | 0.02 | % |
| TXGE | 2920.29 | % |
| SPZI | 0.01 | % |
| AABB | 0.03 | % |
| WRFX | 0.01 | % |
| ICBU | 0.01 | % |
| AMXVF | 1.05 | 10.53% |
| IGPK | 0.01 | % |
| HYSR | 0.02 | % |
| HTZZ | 24.68 | 1.52% |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| VEGPF Daily Charts |
VEGPF Intraday Charts |
Whats New @ Bazaartrend |
VEGPF Free Analysis |
|
|
VEGPF Important Levels Intraday
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.77 |
VEGPF Forecast November 2024
| 4th UP Forecast | 2.21 |
| 3rd UP Forecast | 2.07 |
| 2nd UP Forecast | 1.98 |
| 1st UP Forecast | 1.9 |
| 1st DOWN Forecast | 1.64 |
| 2nd DOWN Forecast | 1.56 |
| 3rd DOWN Forecast | 1.47 |
| 4th DOWN Forecast | 1.33 |
VEGPF Weekly Forecast
| 4th UP Forecast | 3.43 |
| 3rd UP Forecast | 2.90 |
| 2nd UP Forecast | 2.57 |
| 1st UP Forecast | 2.24 |
| 1st DOWN Forecast | 1.30 |
| 2nd DOWN Forecast | 0.97 |
| 3rd DOWN Forecast | 0.64 |
| 4th DOWN Forecast | 0.11 |
VEGPF Forecast2024
| 4th UP Forecast | 4.53 |
| 3rd UP Forecast | 3.64 |
| 2nd UP Forecast | 3.1 |
| 1st UP Forecast | 2.55 |
| 1st DOWN Forecast | 0.99 |
| 2nd DOWN Forecast | 0.44 |
| 3rd DOWN Forecast | -0.1 |
| 4th DOWN Forecast | -0.99 |
Vectura Group plc ( PINK USA Symbol : VEGPF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VEGPF Business Profile
Vectura Group plc engages in the design, development, and supply of pharmaceutical products related to inhalation. Its products include flutiform, flutiform K-haler, Ultibro Breezhaler, Seebri Breezhaler, Enerzair Breezhaler, AirFluSal Forspiro, Airbufo Forspiro, Fluticasone Propionate and Salmeterol, Incruse Ellipta, Anoro Ellipta, Trelegy Ellipta, Relvar/Breo Ellipta, and Breelib. The company also provides formulation, process development and tech transfer, pharmaceutical analysis, product manufacturing, and device platforms services, as well as regulatory affairs, device vigilance, and pharmacovigilance services. In addition, it is developing VR315 (US), a generic Advair. Further, the company offers dry powder and pressurized metered dose inhalers, as well as vibrating mesh and jet nebulizers. Vectura Group plc was incorporated in 1997 and is based in Chippenham, the United Kingdom. Address: One Prospect West, Chippenham, United Kingdom, SN14 6FH
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service